AVXL
Anavex Life Sciences Corp. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -22.2% ·
share flow -11.7% ·
net new positions -20.0%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | -1 | 31.52M | $81.72M | +7 | −8 |
| Q1 2026 | 83 | +4 | 34.46M | $105.82M | +13 | −9 |
| Q4 2025 | 79 | +2 | 31.53M | $112.26M | +2 | — |
| Q3 2025 | 14 | 0 | 20.35M | $181.11M | — | — |
| Q2 2025 | 11 | -2 | 18.83M | $173.63M | — | −2 |
| Q1 2025 | 10 | -1 | 6.83M | $58.56M | — | −1 |
| Q4 2024 | 11 | +3 | 6.21M | $66.68M | +3 | — |
| Q3 2024 | 7 | -2 | 3.52M | $20.02M | — | −2 |
| Q2 2024 | 9 | — | 3.99M | $16.85M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 1.88M | +2.8% | $10.70M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.88M | +2.8% | $10.70M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Two Sigma Investments ✦ | 830.62K | -18.0% | $4.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Millennium Management ✦ | 340.99K | +801.8% | $1.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 243.80K | -47.7% | $1.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 136.64K | +202.2% | $776,137 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 136.64K | +202.2% | $776,137 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 136.64K | +202.2% | $776,137 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 63.11K | +17.3% | $359,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 25.52K | -94.3% | $144,982 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 25.52K | -94.3% | $144,982 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| D. E. Shaw & Co. | $246,258 | was 0.0% |
| Marshall Wace | $166,062 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 39.00K shares, $119 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.